Faculty Opinions recommendation of 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of…

By N. Wong. 2014

1,044 citations recorded by the source corpus.

Subfields: Surgery

View Paper: https://www.semanticscholar.org/paper/5b734d3926c1c944e41e732aed356019383fa2e3

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Surgery

1. I. Graham
2. T. Ivanova
3. M. S. Kirkman
4. Judith Hochman
5. S. Grundy
6. R. Eckel
7. Alberico L. Catapano
8. I. Lee

Citations in the corpus

• 2016 European Guidelines on cardiovascular disease prevention in clinical practice (2016, background): “There are no data on the right age to begin collecting such information in the general population, but some guidelines advocate starting at age 40 years.(190) Repeating such assessments occasionally, such as every 5 years, is recommended, but there are no data to guide this interval.”
• Reprint: 2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk. (2014, methodology): “B (Moderate) CQ3: ES1 (high) IIa A *Refer to 2013 Blood Cholesterol Guideline for guidance on who would benefit from LDL-C lowering (4).”
• National lipid association recommendations for patient-centered management of dyslipidemia: part 1--full report. (2015, methodology): “A patient-centered approach dictates that clinical judgment take into account the circumstances, objectives, and preferences of each individual patient.(3,14,15) The patient should be an active participant in the process, having engaged with the clinician in a dialog about the objectives of therapy,”
• 2016 European Guidelines on cardiovascular disease prevention in clinical practice. (2016, background): “There are no data on the right age to begin collecting such information in the general population, but some guidelines advocate starting at age 40 years.(190) Repeating such assessments occasionally, such as every 5 years, is recommended, but there are no data to guide this interval.”
• Type 1 Diabetes Through the Life Span: A Position Statement of the American Diabetes Association (2014, background): “Unfortunately, there are no blood pressure intervention trials with CVD end points in type 1 diabetes and only one LDL cholesterol–lowering trial (85).”